Who has invested in Leap Therapeutics?

Winklevoss Capital are named among the investors backing Leap Therapeutics.

Leap Therapeutics Funding: $99M Raised, Series B

Leap Therapeutics funding overview

Leap Therapeutics is based in Cambridge, MA. Leap Therapeutics has raised $99M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B. Investors on record include Winklevoss Capital.

Leap Therapeutics at a glance

Total raised: $99M
Latest round: Series B
Headquarters: Cambridge, MA
Notable investors: Winklevoss Capital

Frequently asked about Leap Therapeutics funding

How much has Leap Therapeutics raised?: Leap Therapeutics has raised $99M in total disclosed funding across the rounds on record.
Who has invested in Leap Therapeutics?: Winklevoss Capital are named among the investors backing Leap Therapeutics.
What was the latest Leap Therapeutics funding round?: The most recent disclosed round is a Series B.
Where is Leap Therapeutics based?: Leap Therapeutics is based in Cambridge, MA.

Totals shown for Leap Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

Leap Therapeutics Funding: $99M Raised, Series B

Leap Therapeutics funding overview

Leap Therapeutics at a glance

Frequently asked about Leap Therapeutics funding

Companies related to Leap Therapeutics (26)

Browse related funding lists (5)